Mohanty Pranati, Jena Rabindra Kumar, Sethy Sudha
Assistant Professor, Department of Pathology, S.C.B. Medical College and Hospital, Cuttack, Odisha, India.
Professor and Head, Department of Clinical Haematology, S.C.B. Medical College and Hospital, Cuttack, Odisha, India.
J Clin Diagn Res. 2017 Mar;11(3):EC19-EC22. doi: 10.7860/JCDR/2017/23286.9492. Epub 2017 Mar 1.
Sickle Cell Anaemia (SCA) is one of the commonest haemoglobinopathies due to a point mutation (A→T) of the β-globin gene. Out of five haplotypes, the Arab-Indian haplotype present in India is one of the least severe phenotype and least studied also. It is characterized by lifelong haemolytic anaemia requiring red cell transfusion leading to iron overload. In contrast, there is very high incidence of deficiency of iron, folic acid and vitamin B12.
Our objective was to access the Iron status of SCA patients and to find its correlation with various parameters like red cell transfusion, haemolysis and serum hepcidin.
This was a cross-sectional study conducted on 208 patients for a period of five years. Complete Blood Count (CBC), iron profile, haemolytic parameters and transfusion requirement were studied and data compared with 52 healthy controls.
Few patients (9.6%) revealed significant iron overload (Serum ferritin > 1000 ng/ml). In majority (80.8%) it was either normal or border line raised (300 to 1000 ng/ml) or iron deficiency was noted in a small fraction (9.6%). Frequency of transfusion is the principal factor which positively correlated with level of iron load (p<0.001) while parameters of haemolysis and serum hepcidin level play an insignificant role in this context (p= 0.0634).
This study supports the notion that the presentation of SCA patients in India is of "Viscosity - Vaso-Occlusive Crisis (VOC) phenotype" with high incidence of VOC, low haemolytic rate and transfusion requirement. Iron deficiency may be present in SCA patients requiring Iron supplementation. We suggest further studies to establish the role of hepcidin, ferroportin and other factors that control iron absorption in these patients.
镰状细胞贫血(SCA)是最常见的血红蛋白病之一,由β-珠蛋白基因的点突变(A→T)引起。在五种单倍型中,印度存在的阿拉伯-印度单倍型是表型最不严重且研究最少的之一。其特征为终身溶血性贫血,需要红细胞输血,从而导致铁过载。相比之下,铁、叶酸和维生素B12缺乏的发生率非常高。
我们的目标是评估SCA患者的铁状态,并找出其与红细胞输血、溶血和血清铁调素等各种参数的相关性。
这是一项对208例患者进行了五年的横断面研究。研究了全血细胞计数(CBC)、铁代谢指标、溶血参数和输血需求,并将数据与52名健康对照进行比较。
少数患者(9.6%)显示出明显的铁过载(血清铁蛋白>1000 ng/ml)。大多数患者(80.8%)铁状态正常或临界升高(300至1000 ng/ml),或一小部分患者(9.6%)存在缺铁。输血频率是与铁负荷水平呈正相关的主要因素(p<0.001),而在此背景下,溶血参数和血清铁调素水平起的作用不显著(p = 0.0634)。
本研究支持这样一种观点,即印度的SCA患者表现为“黏滞-血管闭塞性危机(VOC)表型”,VOC发生率高,溶血率低且有输血需求。需要补充铁剂的SCA患者可能存在缺铁情况。我们建议进一步开展研究,以确定铁调素、铁转运蛋白和其他控制这些患者铁吸收的因素的作用。